89 related articles for article (PubMed ID: 17134897)
1. Dystrophin-dependent muscle degeneration requires a fully functional contractile machinery to occur in C. elegans.
Mariol MC; Martin E; Chambonnier L; Ségalat L
Neuromuscul Disord; 2007 Jan; 17(1):56-60. PubMed ID: 17134897
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy.
Giacomotto J; Pertl C; Borrel C; Walter MC; Bulst S; Johnsen B; Baillie DL; Lochmüller H; Thirion C; Ségalat L
Hum Mol Genet; 2009 Nov; 18(21):4089-101. PubMed ID: 19648295
[TBL] [Abstract][Full Text] [Related]
3. Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans.
Gieseler K; Grisoni K; Ségalat L
Curr Biol; 2000 Sep; 10(18):1092-7. PubMed ID: 10996789
[TBL] [Abstract][Full Text] [Related]
4. Loss of dystrophin and the microtubule-binding protein ELP-1 causes progressive paralysis and death of adult C. elegans.
Hueston JL; Suprenant KA
Dev Dyn; 2009 Aug; 238(8):1878-86. PubMed ID: 19582871
[TBL] [Abstract][Full Text] [Related]
5. Blocking of striated muscle degeneration by serotonin in C. elegans.
Carre-Pierrat M; Mariol MC; Chambonnier L; Laugraud A; Heskia F; Giacomotto J; Ségalat L
J Muscle Res Cell Motil; 2006; 27(3-4):253-8. PubMed ID: 16791712
[TBL] [Abstract][Full Text] [Related]
6. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans.
Gaud A; Simon JM; Witzel T; Carre-Pierrat M; Wermuth CG; Ségalat L
Neuromuscul Disord; 2004 Jun; 14(6):365-70. PubMed ID: 15145337
[TBL] [Abstract][Full Text] [Related]
7. The SLO-1 BK channel of Caenorhabditis elegans is critical for muscle function and is involved in dystrophin-dependent muscle dystrophy.
Carre-Pierrat M; Grisoni K; Gieseler K; Mariol MC; Martin E; Jospin M; Allard B; Ségalat L
J Mol Biol; 2006 Apr; 358(2):387-95. PubMed ID: 16527307
[TBL] [Abstract][Full Text] [Related]
8. Dystrophin protects the sarcolemma from stresses developed during muscle contraction.
Petrof BJ; Shrager JB; Stedman HH; Kelly AM; Sweeney HL
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3710-4. PubMed ID: 8475120
[TBL] [Abstract][Full Text] [Related]
9. Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process.
Brouilly N; Lecroisey C; Martin E; Pierson L; Mariol MC; Qadota H; Labouesse M; Streichenberger N; Mounier N; Gieseler K
Hum Mol Genet; 2015 Nov; 24(22):6428-45. PubMed ID: 26358775
[TBL] [Abstract][Full Text] [Related]
10. Muscular degeneration in the absence of dystrophin is a calcium-dependent process.
Mariol MC; Ségalat L
Curr Biol; 2001 Oct; 11(21):1691-4. PubMed ID: 11696327
[TBL] [Abstract][Full Text] [Related]
11. Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of
Hewitt JE; Pollard AK; Lesanpezeshki L; Deane CS; Gaffney CJ; Etheridge T; Szewczyk NJ; Vanapalli SA
Dis Model Mech; 2018 Dec; 11(12):. PubMed ID: 30396907
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of dystrobrevin delays locomotion defects and muscle degeneration in a dystrophin-deficient Caenorhabditis elegans.
Gieseler K; Grisoni K; Mariol MC; Ségalat L
Neuromuscul Disord; 2002 May; 12(4):371-7. PubMed ID: 12062255
[TBL] [Abstract][Full Text] [Related]
13. A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans.
Nyamsuren O; Faggionato D; Loch W; Schulze E; Baumeister R
Dev Biol; 2007 Dec; 312(1):193-202. PubMed ID: 17961535
[TBL] [Abstract][Full Text] [Related]
14. Febuxostat ameliorates muscle degeneration and movement disorder of the dystrophin mutant model in Caenorhabditis elegans.
Yoshina S; Izuhara L; Mashima R; Maejima Y; Kamatani N; Mitani S
J Physiol Sci; 2023 Nov; 73(1):28. PubMed ID: 37950170
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission.
Bessou C; Giugia JB; Franks CJ; Holden-Dye L; Ségalat L
Neurogenetics; 1998 Dec; 2(1):61-72. PubMed ID: 9933302
[TBL] [Abstract][Full Text] [Related]
16. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
17. Reduced IGF signaling prevents muscle cell death in a Caenorhabditis elegans model of muscular dystrophy.
Oh KH; Kim H
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19024-9. PubMed ID: 24191049
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
19. Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable.
Harper SQ; Crawford RW; DelloRusso C; Chamberlain JS
Hum Mol Genet; 2002 Aug; 11(16):1807-15. PubMed ID: 12140183
[TBL] [Abstract][Full Text] [Related]
20. Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs.
Tegeler CJ; Grange RW; Bogan DJ; Markert CD; Case D; Kornegay JN; Childers MK
Muscle Nerve; 2010 Jul; 42(1):130-2. PubMed ID: 20544944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
